|
Pre-clinical Evaluation of LSD1 Inhibitors for the Treatment of Pediatric Ewing sarcoma: Defining the Biomarkers of Sensitivity and Mechanisms of Resistance |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope |
|
Role of Kindlin-3 In Natural Killer Cell Mediated Tumor Killing |
Children’s Hospital of Wisconsin - Milwaukee |
Northwestern Mutual Foundation |
|
Bad Influence: EWS/FLI Alters LSD1 and NuRD Interactions to Enforce Oncogenic Function in Ewing’s |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
|
Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression - Melanie Vincent, PhD (2016) |
University of Colorado Denver |
The Swifty Foundation |
|
Investigating Racial Disparities in Pediatric Acute Leukemia |
University of California San Francisco |
Northwestern Mutual Foundation |
|
Pre-clinical Testing of Novel Glutamine Metabolic Inhibitors in MYC-driven Medulloblastoma |
The Johns Hopkins University School of Medicine |
The Swifty Foundation |
|
CD47-blocking Oncolytic Vaccinia Viruses as Biotherapeutics for Pediatric Solid Tumors |
St. Jude Children’s Research Hospital |
Cure4Cam Childhood Cancer Foundation |
|
Targeting the Function of Ezrin in Rhabdomyosarcoma - Neetu Gupta, PhD & Peter Anderson, MD (2016) |
The Cleveland Clinic Foundation |
Flashes of Hope |
|
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
|
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
